Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia
ObjectiveRituximab (RTX) has been widely used for primary nephrotic syndrome (PNS) in children of frequent relapse or hormonal dependence. The authors applied RTX for childhood PNS in Ningxia for the first time and examined its efficacy.MethodsFrom January 1, 2020 to December 31, 2022, 7 PNS childre...
Main Authors: | Wu Yang, Xiao-e Wang, Jia-le Gu, Li-juan Ma, Bai-ge Su, Hui-jie Xiao, Yong Yao, Hong-wen Zhang |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Nephrology
2024-02-01
|
Series: | Linchuang shenzangbing zazhi |
Subjects: | |
Online Access: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.02.003 |
Similar Items
-
Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
by: Ji Hyun Kim, et al.
Published: (2017-09-01) -
Rituximab Use in the Management of Childhood Nephrotic Syndrome
by: Mahmoud Kallash, et al.
Published: (2019-05-01) -
Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center
by: Rita Gomes, et al.
Published: (2022-10-01) -
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
by: Yiyun Song, et al.
Published: (2023-07-01) -
Rituximab in steroid resistant nephrotic syndrome
by: Agomoni Chaki, et al.
Published: (2019-07-01)